Taiwan FDA registration 23f556fa3e8e302cff835af03c7e9aa5
"Siemens" glucohexokinase reagent
TW: “西門子” 葡萄糖己糖激酶試劑
Taiwan·Risk Class 2·RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.·Registered Oct 26, 2018 – Oct 26, 2028ActiveRegistration details
- Analysis ID
- 23f556fa3e8e302cff835af03c7e9aa5
- Customs Code
- DHA05603175605
Company information
- Manufacturer Country
- United Kingdom;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- This product needs to be used with Atellica CH Analyzer to quantitatively detect glucose concentration in human serum, cerebrospinal fluid, plasma (heparin lithium, EDTA potassium, sodium chloride/potassium oxalate) and urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- import
Dates and status
- Registration Date
- Oct 26, 2018
- Expiry Date
- Oct 26, 2028
About this record
Access comprehensive regulatory information for "Siemens" glucohexokinase reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 23f556fa3e8e302cff835af03c7e9aa5 and manufactured by RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices